B2M and neoplasm: Because the B2M gene is related to T cell immune recognition, its high frequency mutation or deletion makes DLBCL tumor cells insensitive to cytotoxic T cell-mediated killing, suggesting that tumors evade immune surveillance mainly via B2M deletion 23.